CIK 0001724521 · Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473898435
- Phone
- (510) 694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-21 | Azoy Alexander Chief Accounting Officer | Option exercise 10b5-1 | +2,827 | $15.44 | $44K | 42,408 |
| 2026-08-21 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −2,827 | $30.00 | $85K | 39,581 |
| 2026-08-21 | Azoy Alexander Chief Accounting Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,827 | 3,073 | ||
| 2026-06-01 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −2,562 | $25.77 | $66K | 39,581 |
| 2026-01-23 | Azoy Alexander Chief Accounting Officer | Grant or award | +21,050 | 39,581 | ||
| 2026-01-23 | Azoy Alexander Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +14,050 | 14,050 | ||
| 2025-12-18 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −4,343 | $22.25 | $97K | 18,531 |
| 2025-12-17 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −2,113 | $22.16 | $47K | 22,874 |
| 2025-12-16 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −2,376 | $21.88 | $52K | 24,987 |
| 2025-11-26 | Azoy Alexander Chief Accounting Officer | Option exercise 10b5-1 | +1,900 | $13.33 | $25K | 29,263 |
| 2025-11-26 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −1,900 | $26.00 | $49K | 27,363 |
| 2025-11-26 | Azoy Alexander Chief Accounting Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −1,900 | 9,500 | ||
| 2025-09-29 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −2,831 | $13.00 | $37K | 27,363 |
| 2025-09-05 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −1,579 | $11.88 | $19K | 30,194 |
| 2025-01-23 | Azoy Alexander Chief Accounting Officer | Grant or award | +17,100 | 30,194 | ||
| 2025-01-23 | Azoy Alexander Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +11,400 | 11,400 | ||
| 2024-12-19 | Azoy Alexander Chief Accounting Officer | Returned to the company 10b5-1 | −3,007 | $15.17 | $46K | 13,094 |
| 2024-12-15 | Azoy Alexander Chief Accounting Officer | Shares withheld for taxes | −2,969 | $16.08 | $48K | 16,101 |
| 2024-12-02 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −201 | $15.32 | $3K | 19,070 |
| 2024-08-13 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −1,357 | $14.97 | $20K | 19,070 |
Page 1 of 2 · 22 trades